NDC Code(s) : 35573-300-10
Packager : Burel Pharmaceuticals, Inc
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| URAMIT MBMethenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate CAPSULE | |||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||
PRINCIPAL DISPLAY PANEL
NDC 35573-300-10
URAMIT MB™
EACH CAPSULE CONTAINS
| Methenamine | 118 mg |
| Sodium Phosphate Monobasic | 40.8 mg |
| Phenyl Salicylate | 36 mg |
| Methylene Blue | 10 mg |
| Hyoscyamine Sulfate | 0.12 mg |
Rx ONLY
100 Capsules
URAMIT MB™ is a trademark of Burel Pharmaceuticals, Inc
Manufactured for:
Burel Pharmaceuticals, Inc
Richland, MS 39218








